ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 Efficacy & Safety of Continuing Enza in Chemo-Naïve mCRPC Patients Treated With Docetaxel + Prednisolone Who Have Progressed on Enza: Phase 3b PRESIDE Study
By
ASCO Genitourinary Cancers Symposium
FEATURING
Axel Merseburger
By
ASCO Genitourinary Cancers Symposium
FEATURING
Axel Merseburger
65 views
February 24, 2022
Login to view comments.
Click here to Login
Videos